Jin Medical International (ZJYL) Receivables (2022 - 2025)
Jin Medical International (ZJYL) has disclosed Receivables for 4 consecutive years, with $20.2 million as the latest value for Q3 2025.
- Quarterly Receivables rose 232.02% to $20.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $20.2 million through Sep 2025, up 232.02% year-over-year, with the annual reading at $20.2 million for FY2025, 232.02% up from the prior year.
- Receivables hit $20.2 million in Q3 2025 for Jin Medical International, up from $6.1 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $20.2 million in Q3 2025 to a low of $4.0 million in Q3 2022.
- Historically, Receivables has averaged $9.5 million across 4 years, with a median of $6.9 million in 2023.
- Biggest five-year swings in Receivables: decreased 20.34% in 2024 and later surged 232.02% in 2025.
- Year by year, Receivables stood at $4.0 million in 2022, then soared by 93.05% to $7.6 million in 2023, then fell by 20.34% to $6.1 million in 2024, then soared by 232.02% to $20.2 million in 2025.
- Business Quant data shows Receivables for ZJYL at $20.2 million in Q3 2025, $6.1 million in Q3 2024, and $7.6 million in Q3 2023.